W Communication Agency

Brand Awareness Campaign



Vimovo® is a prescription only medicine (POM) used for the relief of symptoms of chronic progressive inflammatory diseases, such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. W was asked to develop a brand awareness campaign for Vimovo®, including print and digital deliverables aimed at hospital-based specialists and General Practitioners based in Norway.

Using our knowledge of the specific regulations on the promotion of a POM in Norway, the most popular healthcare journals / websites read by Norwegian Healthcare Professionals (HCPs), and the collecting of further insights from interviewing the Key Account Managers. W developed a brand awareness campaign targeted at the main print and digital channels to maximize the brand’s share of voice in the market.


Once all the channels had been identified, both print and web, a phased timeline for implementing the Vimovo® brand awareness campaign was developed. Since print had the largest audience, W recommended that Grünenthal initially place the Vimovo® ad in the journals with the largest subscription base: Dagens Medisin and Tidsskriftet. Using these advertisements for inspiration, W also created a number of website banners, that were also placed on websites most visited by target HCPs, thereby further increasing the brand’s share of voice in Norway.



We chose W for several reasons! We saw the opportunity to create a strong strategic cooperation with W and that they had the ability to deliver according to our objectives, timelines and needs. W was also able to offer good project management in a way that matched our need for good cross-functional working. We look forward to continuing to develop our collaboration with W on new projects.

Anders Ranebjer, Head of Marketing Nordic, Grünenthal .


Want to know more? Contact Account Director Sunil Ramkali.

Get news and inspiration from W straight to your inbox! Sign up for Whispers, our quarterly newsletter, right here: